0001437749-17-012085.txt : 20170630 0001437749-17-012085.hdr.sgml : 20170630 20170630160308 ACCESSION NUMBER: 0001437749-17-012085 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170510 FILED AS OF DATE: 20170630 DATE AS OF CHANGE: 20170630 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Diffusion Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001053691 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 300645032 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2020 AVON COURT STREET 2: SUITE 4 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 BUSINESS PHONE: (434) 220-0718 MAIL ADDRESS: STREET 1: 2020 AVON COURT STREET 2: SUITE 4 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 FORMER COMPANY: FORMER CONFORMED NAME: RestorGenex Corp DATE OF NAME CHANGE: 20140307 FORMER COMPANY: FORMER CONFORMED NAME: Stratus Media Group, Inc DATE OF NAME CHANGE: 20080722 FORMER COMPANY: FORMER CONFORMED NAME: FERIS INTERNATIONAL, INC. DATE OF NAME CHANGE: 20080228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kalergis David G CENTRAL INDEX KEY: 0001663574 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37942 FILM NUMBER: 17942078 MAIL ADDRESS: STREET 1: 2020 AVON COURT STREET 2: SUITE 4 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 4/A 1 rdgdoc.xml FORM 4/A X0306 4/A 2017-05-10 2017-05-12 0001053691 Diffusion Pharmaceuticals Inc. DFFN 0001663574 Kalergis David G 2020 AVON COURT, SUITE 4 CHARLOTTESVILLE VA 22902 1 1 Chairman and CEO Stock Option (Right to Buy) 2.96 2017-05-10 4 A 0 41000 0 A 2027-05-10 Common Stock 41000 41000 D The shares underlying the options vest in equal parts on the last calendar day of each month until fully vested on May 31, 2020. This amendment is being filed solely to correct an error in the reported exercise price of the Derivative Security in the original filing. /s/ Ben L. Shealy, attorney-in-fact for David G. Kalergis 2017-06-30